Andorra vs Sri Lanka: Previously treated cases tested for RR-/MDR-TB
Andorra
100.0%
in 2014
Sri Lanka
100.0%
in 2024
Andorra rank
1st
Sri Lanka rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Andorra
- Sri Lanka
How they compare
Andorra currently reports 100.0% against 100.0% in Sri Lanka, a difference of 0.0%.
Across all 5 years both countries report, Sri Lanka has been ahead every year.
Andorra ranks 1st and Sri Lanka ranks 1st of 180 countries.
Sri Lanka has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Andorra | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.7% | 88.7% | 72.0% | Sri Lanka |
| 2010s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Andorra or Sri Lanka?
- Andorra, at 100.0% against 100.0% in Sri Lanka as of 2014.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Andorra and Sri Lanka?
- 0.0%, with Andorra ahead.
- How many years of comparable data are there for Andorra and Sri Lanka?
- 5 years are reported by both, from 2006 to 2014.
- How do Andorra and Sri Lanka rank globally for previously treated cases tested for rr-/mdr-tb?
- Andorra ranks 1st and Sri Lanka ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.